Literature DB >> 12845716

CD4+ T cell apoptosis induced by anti-CD4 antibodies.

Z Zhang1, Y Zhang, H Zhu, J Yang, G Shen.   

Abstract

To explore the inhibitory effects of anti-CD4 human/murine chimeric antibodies on lymphocyte proliferation, CD4+ T cell apoptosis induced by anti-CD4 antibodies was examined. Annexin-V-FITC and PI double stain method was employed to qualitatively and quantitatively determined CD4+ T cell apoptosis induced by anti-CD4 antibodies. Our results showed that anti-CD4 chimeric antibodies could specifically induce CD4+ T cell apoptosis. The ability of anti-CD4 chimeric antibodies to induce CD4+ T cell apoptosis was related with the presence of monocytes. It is concluded that the further cross-linking of anti-CD4 antibodies is important for inducing CD4+ T cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12845716     DOI: 10.1007/bf02887041

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  4 in total

1.  The conventional CD4+ T cell response to staphylococcal enterotoxin B is modified by its superantigenic activity.

Authors:  R Wen; S Surman; M A Blackman; D L Woodland
Journal:  Cell Immunol       Date:  1997-03-15       Impact factor: 4.868

2.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.

Authors:  I Vermes; C Haanen; H Steffens-Nakken; C Reutelingsperger
Journal:  J Immunol Methods       Date:  1995-07-17       Impact factor: 2.303

3.  A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.

Authors:  G Süss; K Shortman
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

4.  Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals.

Authors:  P D Katsikis; E S Wunderlich; C A Smith; L A Herzenberg; L A Herzenberg
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.